Skip to main content

Milestone 14.A

Convene an advisory meeting focused on facilitating public-private partnerships aimed at accelerating the development of effective therapies for AD and ADRD treatment and prevention.

Success Criteria

Established working groups on: (i) Rapid Data Sharing and Analysis, (ii) Enabling Bidirectional Translation in AD drug development, (iii) Eliminating IP barriers for Target Validation through clinical proof of concept.

Time Required

2013 to 2013

Research Implementation Area

Public Private Partnerships

Activities, Funding Initiatives, and Resources

NIH Enabling Partnerships for Alzheimer’s Disease Drug Development (April 2013)

Relevant Recommendation(s)

2012 AD Summit Recommendations: 1H, 1I, 1K and 6C